abrdn Life Sciences Investors (HQL) Stock Price
HQLStock
$21.67+55.82%52W
Market Cap$658.94M
P/E7.35x
PEG Ratio—
Div yield—
Beta0.71
HQL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)11.90%
Price vs S&P 500 (4W)8.20%
VGM Score64.72
P/E Ratio (Annual)7.35x
Industry Peers — Unclassified(45)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HQLabrdn Life Sciences Investors | D | B | A | $21.67 |
| NVGNuveen AMT-Free Municipal Credit Income Fund | C | D | D | $12.27 |
| TYTRI-Continental Corporation | A | B | B | $35.61 |
| CETCentral Securities Corp. | D | B | B | $55.29 |
| GAMGeneral American Investors Company, Inc. | — | — | A | $67.95 |
| HQHabrdn Healthcare Investors | F | B | A | $23.61 |
| MQYBlackrock Muni Yield Quality Fund, Inc | D | C | D | $11.15 |
| MYIBLACKROCK MUNIYIELD QUALITY FUND III, INC. | D | C | C | $10.78 |
| MUABlackrock Muni Assets Fund, Inc. | C | C | F | $9.99 |
| PDTJohn Hancock Premium Dividend Fund | — | — | F | $12.62 |
| FAXabrdn Asia-Pacific Income Fund, Inc | A | C | D | $14.60 |
About abrdn Life Sciences Investors
abrdn Life Sciences Investors is a non-diversified, closed-end fund focused on long-term capital appreciation in the life sciences sector. It invests in both public and private companies with above-average growth potential. The fund's strategy targets companies believed capable of delivering superior returns.